Norethindrone Acetate (KAISER FOUNDATION HOSPITALS)
Welcome to the PulseAid listing for the Norethindrone Acetate drug offered from KAISER FOUNDATION HOSPITALS. This Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | KAISER FOUNDATION HOSPITALS |
NON-PROPRIETARY NAME: | Norethindrone Acetate |
SUBSTANCE NAME: | NORETHINDRONE ACETATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-03-01 |
END MARKETING DATE: | 0000-00-00 |
Norethindrone Acetate HUMAN PRESCRIPTION DRUG Details:
Item Description | Norethindrone Acetate from KAISER FOUNDATION HOSPITALS |
LABELER NAME: | KAISER FOUNDATION HOSPITALS |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2017-03-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0179-0227_e846661f-546c-4ae8-917f-b6ac6579d632 |
PRODUCT NDC: | 0179-0227 |
APPLICATION NUMBER: | ANDA091090 |
Other NORETHINDRONE ACETATE Pharmaceutical Manufacturers / Labelers: